Marks Robert M, Fung Alice, Cruite Irene, Blevins Kasina, Lalani Tasneem, Horvat Natally, Protopapas Zenon, Chaudhry Humaira, Bijan Bijan, Shiehmorteza Masoud, Nepal Pankaj, Tang An
Department of Radiology, Naval Medical Center San Diego, 34800 Bob Wilson Dr. Suite 204, San Diego, CA, 92134, USA.
Department of Radiology, University of California San Diego, San Diego, CA, USA.
Abdom Radiol (NY). 2023 Aug;48(8):2514-2524. doi: 10.1007/s00261-023-03951-9. Epub 2023 May 26.
To understand the practice and determinants of non-academic radiologists regarding LI-RADS and the four current LI-RADS algorithms: CT/MRI, contrast-enhanced ultrasound (CEUS), ultrasound (US), and CT/MRI Treatment Response.
Seven themes were covered in this international survey, as follows: (1) demographics of participants and sub-specialty, (2) HCC practice and interpretation, (3) reporting practice, (4) screening and surveillance, (5) HCC imaging diagnosis, (6) treatment response, and (7) CT and MRI technique.
Of the 232 participants, 69.4% were from the United States, 25.0% from Canada, and 5.6% from other countries and 45.9% were abdominal/body imagers. During their radiology training or fellowship, no formal HCC diagnostic system was used by 48.7% and LI-RADS was used by 44.4% of participants. In their current practice, 73.6% used LI-RADS, 24.7% no formal system, 6.5% UNOS-OPTN, and 1.3% AASLD. Barriers to LI-RADS adoption included lack of familiarity (25.1%), not used by referring clinicians (21.6%), perceived complexity (14.5%), and personal preference (5.3%). The US LI-RADS algorithm was used routinely by 9.9% of respondents and CEUS LI-RADS was used by 3.9% of the respondents. The LI-RADS treatment response algorithm was used by 43.5% of the respondents. 60.9% of respondents thought that webinars/workshops on LI-RADS Technical Recommendations would help them implement these recommendations in their practice.
A majority of the non-academic radiologists surveyed use the LI-RADS CT/MR algorithm for HCC diagnosis, while nearly half use the LI-RADS TR algorithm for assessment of treatment response. Less than 10% of the participants routinely use the LI-RADS US and CEUS algorithms.
了解非学术型放射科医生对肝脏影像报告和数据系统(LI-RADS)以及当前四种LI-RADS算法(CT/MRI、对比增强超声(CEUS)、超声(US)和CT/MRI治疗反应)的应用情况及影响因素。
本次国际调查涵盖七个主题,如下:(1)参与者的人口统计学特征和亚专业;(2)肝细胞癌(HCC)的诊疗实践与解读;(3)报告实践;(4)筛查与监测;(5)HCC影像诊断;(6)治疗反应;(7)CT和MRI技术。
232名参与者中,69.4%来自美国,25.0%来自加拿大,5.6%来自其他国家,45.9%为腹部/体部影像诊断医生。在放射科培训或进修期间,48.7%的参与者未使用正式的HCC诊断系统,44.4%的参与者使用LI-RADS。在当前实践中,73.6%的人使用LI-RADS,24.7%未使用正式系统,6.5%使用器官共享联合网络(UNOS)-器官分配与移植网络(OPTN)标准,1.3%使用美国肝病研究协会(AASLD)标准。采用LI-RADS的障碍包括不熟悉(25.1%)、转诊临床医生未使用(21.6%)、感觉复杂(14.5%)和个人偏好(5.3%)。9.9%的受访者常规使用美国LI-RADS算法,3.9%的受访者使用CEUS LI-RADS算法。43.5%的受访者使用LI-RADS治疗反应算法。60.9%的受访者认为关于LI-RADS技术建议的网络研讨会/工作坊将有助于他们在实践中实施这些建议。
接受调查的大多数非学术型放射科医生使用LI-RADS CT/MR算法进行HCC诊断,而近一半的人使用LI-RADS治疗反应(TR)算法评估治疗反应。不到10%的参与者常规使用LI-RADS US和CEUS算法。